PL2095118T3 - Sposób przewidywania fosfolipidozy wywołanej właściwościami substancji - Google Patents
Sposób przewidywania fosfolipidozy wywołanej właściwościami substancjiInfo
- Publication number
- PL2095118T3 PL2095118T3 PL07848189T PL07848189T PL2095118T3 PL 2095118 T3 PL2095118 T3 PL 2095118T3 PL 07848189 T PL07848189 T PL 07848189T PL 07848189 T PL07848189 T PL 07848189T PL 2095118 T3 PL2095118 T3 PL 2095118T3
- Authority
- PL
- Poland
- Prior art keywords
- substance
- predicting
- cmc
- phospholipidosis
- substance properties
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 7
- 239000003945 anionic surfactant Substances 0.000 abstract 2
- 230000001747 exhibiting effect Effects 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20065774A FI119745B (fi) | 2006-12-05 | 2006-12-05 | Menetelmä aineen fosfolipidoosia aiheuttavien ominaisuuksien ennustamiseksi |
| EP07848189A EP2095118B1 (en) | 2006-12-05 | 2007-12-04 | Method of predicting phospholipidosis inducing properties of a substance |
| PCT/FI2007/050657 WO2008068383A1 (en) | 2006-12-05 | 2007-12-04 | Method of predicting phospholipidosis inducing properties of a substance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2095118T3 true PL2095118T3 (pl) | 2011-08-31 |
Family
ID=37623790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07848189T PL2095118T3 (pl) | 2006-12-05 | 2007-12-04 | Sposób przewidywania fosfolipidozy wywołanej właściwościami substancji |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8093058B2 (pl) |
| EP (1) | EP2095118B1 (pl) |
| JP (1) | JP5148625B2 (pl) |
| CN (1) | CN101600964A (pl) |
| AT (1) | ATE500504T1 (pl) |
| DE (1) | DE602007012934D1 (pl) |
| DK (1) | DK2095118T3 (pl) |
| ES (1) | ES2362379T3 (pl) |
| FI (1) | FI119745B (pl) |
| PL (1) | PL2095118T3 (pl) |
| WO (1) | WO2008068383A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112652364A (zh) * | 2020-11-26 | 2021-04-13 | 深圳晶泰科技有限公司 | 基于从头算模型预测表面活性剂临界胶束浓度的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3316657B2 (ja) * | 1994-02-25 | 2002-08-19 | 株式会社リコー | 非イオン界面活性剤の濃度測定方法 |
| ATE533051T1 (de) * | 2001-07-23 | 2011-11-15 | Phares Pharm Res Nv | Testsystem und verfahren zur auswahl von materialen und formulierungen |
| WO2005052154A1 (ja) * | 2003-11-27 | 2005-06-09 | Takeda Pharmaceutical Company Limited | 薬物の毒性予測方法 |
| WO2005064344A1 (ja) | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | 脂質代謝異常症の予測方法 |
| US20100129790A1 (en) * | 2005-02-17 | 2010-05-27 | Takeda Pharmaceutical Limited | Method for Determining Phospholipidosis |
| GB2434445A (en) * | 2006-01-13 | 2007-07-25 | Cytokinetics Inc | Assay for phospholipidosis |
| US9250249B2 (en) * | 2008-09-08 | 2016-02-02 | Enzo Biochem, Inc. | Autophagy and phospholipidosis pathway assays |
| US8313949B2 (en) * | 2009-04-16 | 2012-11-20 | Nextcea Inc. | Detecting phospholipidosis and diagnosing lysosomal storage disorders |
-
2006
- 2006-12-05 FI FI20065774A patent/FI119745B/fi not_active IP Right Cessation
-
2007
- 2007-12-04 CN CNA2007800509429A patent/CN101600964A/zh active Pending
- 2007-12-04 EP EP07848189A patent/EP2095118B1/en not_active Not-in-force
- 2007-12-04 ES ES07848189T patent/ES2362379T3/es active Active
- 2007-12-04 JP JP2009539773A patent/JP5148625B2/ja not_active Expired - Fee Related
- 2007-12-04 AT AT07848189T patent/ATE500504T1/de active
- 2007-12-04 PL PL07848189T patent/PL2095118T3/pl unknown
- 2007-12-04 US US12/517,880 patent/US8093058B2/en not_active Expired - Fee Related
- 2007-12-04 DK DK07848189.2T patent/DK2095118T3/da active
- 2007-12-04 DE DE602007012934T patent/DE602007012934D1/de active Active
- 2007-12-04 WO PCT/FI2007/050657 patent/WO2008068383A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008068383A1 (en) | 2008-06-12 |
| FI20065774A0 (sv) | 2006-12-05 |
| EP2095118A4 (en) | 2010-03-31 |
| EP2095118B1 (en) | 2011-03-02 |
| JP2010511881A (ja) | 2010-04-15 |
| EP2095118A1 (en) | 2009-09-02 |
| ES2362379T3 (es) | 2011-07-04 |
| ATE500504T1 (de) | 2011-03-15 |
| DK2095118T3 (da) | 2011-06-27 |
| DE602007012934D1 (de) | 2011-04-14 |
| CN101600964A (zh) | 2009-12-09 |
| FI119745B (fi) | 2009-02-27 |
| US8093058B2 (en) | 2012-01-10 |
| FI20065774L (fi) | 2008-06-06 |
| JP5148625B2 (ja) | 2013-02-20 |
| US20100323451A1 (en) | 2010-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX383346B (es) | Composiciones y metodos que comprenden variantes de serina proteasa. | |
| CY1118454T1 (el) | Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες | |
| WO2007098184A3 (en) | Methods and compositions for analyte detection | |
| TR201908247T4 (tr) | Sodyum glikoz birlikte taşıyıcı 1 inhibitörleri. | |
| JO3118B1 (ar) | تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة | |
| MX2010010209A (es) | 4-hidroxipirimidina-5-carboxamidas sustituidas. | |
| ES2570380T3 (es) | Método para determinar la aptitud de inhibidores de EZH2 humano en tratamiento | |
| EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
| NZ589063A (en) | Detection and treatment of pancreatic, ovarian and other cancers using antibodies that specifically bind to denatured CD70 | |
| EP2351575A4 (en) | NEW USE OF GRS PROTEINS OR FRAGMENTS THEREOF | |
| ATE449097T1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer | |
| EA200870029A1 (ru) | Способ применения антагонистов il-6 с ингибиторами протеасом | |
| DK2089343T3 (da) | Click-kemi til fremstilling af reportermolekyler | |
| UA111827C2 (uk) | Спосіб отримання інгенол-3-ангелату | |
| EA201170288A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
| EP2133342A4 (en) | INHIBITOR OF PROTEINTHYROSINE PHOSPHATASE 1B, METHOD OF MANUFACTURE AND APPLICATIONS THEREOF | |
| EA201291180A1 (ru) | Композиции и способы применения терапевтических антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6) | |
| EA201490450A1 (ru) | Новые ингибиторы ферментов | |
| CL2011000295A1 (es) | Compuestos derivados de pirimidil-amino-benzamida; inhibidores de tirosin-quinasa; y su uso en el tratamiento de la hipertension pulmonar. | |
| EA200970597A1 (ru) | Новые бис(диалкиламиды), способ получения и применения | |
| BR112015012331A2 (pt) | autenticação social | |
| ATE553764T1 (de) | Zusammensetzungen und verfahren zur identifizierung von inhibitoren einer retrovirusinfektion | |
| MA32595B1 (fr) | Configuration de formulaire lisible par machine, et systeme et procede de pari | |
| CY1120487T1 (el) | Νεα μεθοδος για τη θεραπεια λοιμωξεων απο ελικοβακτηριδιο του πυλωρου (η. pylori) | |
| SA518392179B1 (ar) | مركبات من مضاد لمستقبل سوماتوستاتين وطرق استخدامها |